Ironwood Pharmaceuticals
IRWD
#6947
Rank
S$0.73 B
Marketcap
S$4.51
Share price
-6.70%
Change (1 day)
-1.97%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2025 (TTM): S$0.11 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are S$0.33 Billion. In 2024 the company made an earning of S$84.49 Million, an increase over its 2023 earnings that were of -S$1.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.11 B41.69%
2024 S$84.49 M-106.88%
2023 -S$1.23 Billion-475.59%
2022 S$0.32 B25.8%
2021 S$0.26 B84.32%
2020 S$0.14 B84.69%
2019 S$76.38 M-125.13%
2018 -S$0.31 Billion100.62%
2017 -S$0.16 Billion43.12%
2016 -S$0.11 Billion-42.73%
2015 -S$0.19 Billion-24.76%
2014 -S$0.25 Billion-30.49%
2013 -S$0.36 Billion275.65%
2012 -S$94.12 Million11.56%
2011 -S$84.37 Million9.38%
2010 -S$77.13 Million-15.21%
2009 -S$90.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nektar Therapeutics
NKTR
-S$0.15 Billion-221.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.96 B 13,890.27%๐Ÿ‡ฌ๐Ÿ‡ง UK